Aekyungchemical Co., Ltd. (161000.KS)
Seoul, KR
Aekyungchemical Co., Ltd. operates as a diverse chemical manufacturing company. Its extensive product range includes versatile, high-performance, and environmentally conscious plasticizing agents. The firm also produces essential industrial intermediates like phthalic anhydride, maleic anhydride, and itaconic acids, along with base oils for lubricants. Furthermore, Aekyungchemical supplies specialized resins for composite materials and protective coatings, various bonding agents, and critical components such as polyisocyanate hardeners (functioning as isocyanate curing agents) and polyester polyols featuring an aromatic structure for urethane systems. Beyond industrial applications, the company extends its offerings to consumer-oriented products, including surfactants (detergents), highly refined glycerin, a variety of polymer-based goods, and chemicals specifically formulated for the construction sector. Additionally, its production capabilities encompass renewable energy solutions like biodiesel and bio heavy oils, as well as advanced cathode materials. Aekyungchemical conducts its business operations across South Korea, Vietnam, and China. The company was founded in 1970 and maintains its main corporate headquarters in Seoul, South Korea.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.24% | -14.79% | -17.26% | +22.73% | +24.39% | +40.13% | +10.59% | -31.03% | +3.21% | +66.88% | +337.89% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-11.6% Q1'26: +0.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-174.2% Q1'26: -13.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-3.4% Q1'26: -12.4% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-0.7% Q1'26: +1.6% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-0.5% Q1'26: +2.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.1% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×12.05× Q1'26: 7.54× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
Dec 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
912.10B
est: 1.17T (-21.8%)
|
867.74B
est: 808.00B (+7.4%)
|
959.82B
est: 953.00B (+0.7%)
|
1.03T
est: 1.08T (-4.2%)
|
1.02T
est: 1.07T (-5.3%)
|
908.85B
est: 856.90B (+6.1%)
|
1.57T
est: 920.90B (+70.5%)
|
2.18T
est: 924.00B (+135.5%)
|
1.64T
est: 808.00B (+103.2%)
|
1.45T
est: 808.00B (+79.7%)
|
953.00B
953.00B – 953.00B
+17.9% YoY
|
1.08T
1.08T – 1.08T
+13.0% YoY
|
1.07T
1.07T – 1.07T
-0.2% YoY
|
856.90B
856.90B – 856.90B
-20.3% YoY
|
920.90B
920.90B – 920.90B
+7.5% YoY
|
924.00B
924.00B – 924.00B
+0.3% YoY
|
| EBITDA |
40.84B
est: 66.77B (-38.8%)
|
80.46B
est: 46.28B (+73.9%)
|
97.56B
est: 54.58B (+78.7%)
|
76.25B
est: 61.68B (+23.6%)
|
60.26B
est: 61.54B (-2.1%)
|
69.45B
est: 49.08B (+41.5%)
|
100.72B
est: 52.74B (+91.0%)
|
130.18B
est: 52.92B (+146.0%)
|
60.66B
est: 38.59B (+57.2%)
|
41.92B
est: 38.59B (+8.6%)
|
45.52B
45.52B – 45.52B
+17.9% YoY
|
51.44B
51.44B – 51.44B
+13.0% YoY
|
51.32B
51.32B – 51.32B
-0.2% YoY
|
40.93B
40.93B – 40.93B
-20.3% YoY
|
43.98B
43.98B – 43.98B
+7.5% YoY
|
44.13B
44.13B – 44.13B
+0.3% YoY
|
| EBIT |
36.74B
est: 47.62B (-22.8%)
|
72.29B
est: 33.00B (+119.0%)
|
89.54B
est: 38.92B (+130.0%)
|
67.29B
est: 43.99B (+53.0%)
|
48.72B
est: 43.89B (+11.0%)
|
57.40B
est: 35.00B (+64.0%)
|
83.97B
est: 37.61B (+123.2%)
|
96.66B
est: 37.74B (+156.1%)
|
22.97B
est: 21.66B (+6.1%)
|
-10.24B
est: 21.66B (-147.3%)
|
25.54B
25.54B – 25.54B
+17.9% YoY
|
28.87B
28.87B – 28.87B
+13.0% YoY
|
28.80B
28.80B – 28.80B
-0.2% YoY
|
22.97B
22.97B – 22.97B
-20.3% YoY
|
24.68B
24.68B – 24.68B
+7.5% YoY
|
24.77B
24.77B – 24.77B
+0.3% YoY
|
| Net Income |
28.33B
est: 46.41B (-38.9%)
|
53.75B
est: 87.52B (-38.6%)
|
65.10B
est: 88.73B (-26.6%)
|
53.09B
est: 67.14B (-20.9%)
|
30.51B
est: 66.51B (-54.1%)
|
44.41B
est: 48.83B (-9.1%)
|
77.37B
est: 59.02B (+31.1%)
|
60.15B
est: 63.85B (-5.8%)
|
3.98B
est: 87.41B (-95.4%)
|
-2.95B
est: 87.41B (-103.4%)
|
88.62B
88.62B – 88.62B
+1.4% YoY
|
67.05B
67.05B – 67.05B
-24.3% YoY
|
66.43B
66.43B – 66.43B
-0.9% YoY
|
48.77B
48.77B – 48.77B
-26.6% YoY
|
58.95B
58.95B – 58.95B
+20.9% YoY
|
63.77B
63.77B – 63.77B
+8.2% YoY
|
| SGA |
30.95B
est: 31.69B (-2.3%)
|
35.96B
est: 21.96B (+63.7%)
|
38.05B
est: 25.91B (+46.9%)
|
27.16B
est: 29.28B (-7.2%)
|
26.75B
est: 29.21B (-8.4%)
|
24.67B
est: 23.29B (+5.9%)
|
32.19B
est: 25.03B (+28.6%)
|
55.82B
est: 25.12B (+122.2%)
|
53.56B
est: 23.48B (+128.1%)
|
53.01B
est: 23.48B (+125.8%)
|
27.69B
27.69B – 27.69B
+17.9% YoY
|
31.29B
31.29B – 31.29B
+13.0% YoY
|
31.22B
31.22B – 31.22B
-0.2% YoY
|
24.90B
24.90B – 24.90B
-20.3% YoY
|
26.76B
26.76B – 26.76B
+7.5% YoY
|
26.85B
26.85B – 26.85B
+0.3% YoY
|
| EPS |
88.50
est: 960.80 (-90.8%)
|
1,678.00
est: 1,812.00 (-7.4%)
|
2,054.00
est: 1,837.00 (+11.8%)
|
1,682.00
est: 1,390.00 (+21.0%)
|
966.47
est: 1,377.00 (-29.8%)
|
1,406.84
est: 1,011.00 (+39.2%)
|
2,301.94
est: 1,222.00 (+88.4%)
|
1,248.60
est: 1,322.00 (-5.6%)
|
82.32
est: 1,812.00 (-95.5%)
|
-61.08
est: 1,812.00 (-103.4%)
|
1,837.00
1,837.00 – 1,837.00
+1.4% YoY
|
1,390.00
1,390.00 – 1,390.00
-24.3% YoY
|
1,377.00
1,377.00 – 1,377.00
-0.9% YoY
|
1,011.00
1,011.00 – 1,011.00
-26.6% YoY
|
1,222.00
1,222.00 – 1,222.00
+20.9% YoY
|
1,322.00
1,322.00 – 1,322.00
+8.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-26 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex Energy&Chemicals 117460.KS | 0.25% | 42.4K | 0.45% |
| 2 | Kodex Dividend Value 325020.KS | 0.02% | 19.6K | 0.30% |
| 3 | Kodex KOSPI 226490.KS | 0.01% | 88.2K | 0.15% |
| 4 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.01% | 7.2K | 0.42% |
| 5 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 20.0K | 0.44% |
| 6 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 58.7K | 0.46% |
| 7 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.00% | 5.4K | 0.33% |
| 8 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 178.2K | 0.39% |
| 9 | Avantis Emerging Markets Equity ETF AVEM | 0.00% | 235.7K | 0.33% |
| 10 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 82.9K | 0.29% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Pyo Kyoung-won | Chief Executive Officer & Chairman of the Board | — | — |
| Seong-wan Kim | Chief Financial Officer, Head of Business Management Division & Internal Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 161000.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
